Connect with us

Politics

UN Launches First-Ever Full Review Of Marijuana’s Status Under International Law

Published

on

For the first time ever, the United Nations (UN) is launching an in-depth review of whether marijuana is properly classified under international drug treaties.

In a related development, the UN’s World Health Organization (WHO) has announced that cannabidiol (CBD), a compound in marijuana that is increasingly used for medical purposes, does not warrant being controlled under the global agreements.

“The Committee recommended that preparations considered to be pure CBD should not be scheduled within the International Drug Control Conventions,” WHO Director-General Tedros Adhanom Ghebreyesus wrote in a letter announcing the moves. “The Committee concluded that there is sufficient evidence to proceed to a Critical Review” of marijuana, hashish, cannabis extracts and THC.

That broader review is set for November, and follows the results of an initial pre-review conducted by WHO’s Expert Committee on Drug Dependence (ECDD) in June.

“A pre-review is the first step of the ECDD’s assessment process, where it is determined whether there is enough robust scientific information to proceed to the next step, called a critical review,” an explanatory document accompanying the new letter reads. “This initial evaluation is also an opportunity to identify gaps in the available scientific data. A critical review is carried out when there is sufficient scientific evidence to allow the ECDD to make informed an recommendation that the substance be placed under international control, or if its level of control should be changed.”

The reviews include analyses of the chemistry, pharmacology, toxicology, epidemiology and therapeutic use of the substances.

If the UN ultimately decides to change marijuana’s status under international law, it would trigger a review on U.S. scheduling, according to provisions of the Controlled Substances Act.

“Thankfully the World Health Organization has accepted the challenge of evaluating the placement of cannabis in the 1962 Single Convention treaty,” Michael Krawitz of Veterans for Medical Cannabis Access told Marijuana Moment. “Cannabis placement in the treaty was done in the absence of scientific evaluation and has provided the basis for a moral campaign against drugs by the USA for many decades. Since our work on medical access to cannabis has been based upon scientific inquiry we know that any rational assessment of the evidence leads the observer to understand cannabis indeed has proven medicinal value and, compared to other medicines, has profoundly fewer negative side effects.”

Here’s what the UN experts have determined so far:

“There are no case reports of abuse or dependence relating to the use of pure CBD. No public health problems have been associated with CBD use,” an annex attached to Ghebreyesus’s letter reads, noting that research has shown it to be effective in treating epilepsy. “CBD has been found to be generally well tolerated with a good safety profile.”

“Cannabidiol (CBD) is not specifically listed in the schedules of the 1961, 1971 or 1988 United Nations International Drug Control Conventions… There is no evidence that CBD as a substance is liable to similar abuse and similar ill-effects as substances in the 1961 or 1971 Conventions such as cannabis or THC, respectively. The Committee recommended that preparations considered to be pure CBD should not be scheduled.”

When it comes to whole-plant marijuana and resin, ECDD’s pre-review found that while “adverse effects” are possible and that cannabis can cause physical dependence, its current categorization in international treaties “may not appear to be consistent with the criteria.”

“Several countries permit the use of cannabis for the treatment of medical conditions such as back pain, sleep disorders, depression, post-injury pain, and multiple sclerosis,” the document says. “The evidence presented to the Committee did not indicate that cannabis plant and cannabis resin were liable to produce ill-effects similar to these other substances that are in Schedule IV of the 1961 Convention on Narcotic Drugs. The inclusion of cannabis and cannabis resin in Schedule IV may not appear to be consistent with the criteria for Schedule IV.”

“The Committee concluded that there is sufficient evidence to proceed to critical review of cannabis plant and cannabis resin at a future ECDD meeting and explore further the appropriateness of their current scheduling within the 1961 Convention.”

With respect to extracts and tinctures of cannabis, the committee similarly identified health issues associated with consumption, but said “there is limited evidence of a withdrawal syndrome upon abrupt cessation.”

The committee also looked at THC itself and isomers of THC, and recommended that both be subject to critical reviews in November.

Ghebreyesus’s letter is addressed to UN Secretary-General Antonio Guterres, who will be the ultimate recipient of WHO’s recommendations on cannabis and related extracts and compounds following the review.

Guterres was prime minister of Portugal when that nation decriminalized all drugs, a move he touted last year in an address to the UN’s Commission on Narcotic Drugs. After the critical reviews are in, that body will vote on whether to alter cannabis’s status under the international treaties.

Marijuana Moment Patreon supporters can see the full text of the new WHO letter on cannabis below:

This premium content is available only for Marijuana Moment supporters on Patreon. Please start a monthly pledge to help us continue our cannabis advocacy journalism. (Please contact [email protected] if you are a patron and have trouble logging in.)
If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!

Tom Angell is the editor of Marijuana Moment. A 15-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for Marijuana.com and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy. (Organization citations are for identification only and do not constitute an endorsement or partnership.)

Politics

Chris Christie Finally Recognizes Marijuana Legalization As States’ Rights Issue

Published

on

Famously anti-marijuana former New Jersey Gov. Chris Christie (R) isn’t jumping on the pro-legalization train any time soon—but new comments suggest he might be softening his opposition a smidge, recognizing marijuana reform as a states’ rights issue.

Speaking at Politicon on Saturday, Christie took a question about his cannabis stance from YouTuber Kyle Kulinski, who asked him to weigh in on studies showing that states with legal marijuana programs experience lower rates of opioid addiction and overdoses compared to non-legal states. He was quick to dismiss the research, contending that other studies show the “exact opposite.”

“I just don’t believe when we’re in the midst of a drug addiction crisis that we need to legalize another drug,” Christie said, echoing comments he’s made as chair of President Donald Trump’s opioids committee.

Then he pivoted, acknowledging that some will push back on his anti-legalization position by pointing out that alcohol is legal. “I get that,” he said, “but I wasn’t here when we legalized alcohol.”

Kulinski seized on that point and asked the former governor if he’d vote to ban alcohol.

“No, I wouldn’t ban it. You can’t put the toothpaste back in the tube, and that’s a big, important argument about marijuana because once you legalize this, that toothpaste never goes back in the tube.”

Christie stood out among other Republican and Democratic contenders during his 2016 presidential run by maintaining that in addition to personally opposing legalization, he’d crack down on legal cannabis states and enforce federal laws nationwide if elected.

“If you’re getting high in Colorado today, enjoy it,” Christie said in 2015. “As of January 2017, I will enforce the federal laws.

So it came as something of a surprise when the former governor went on to say in the Politicon appearance that “states have the right to do what they want to do on this,” signaling a modest shift in his anti-marijuana rhetoric. States should have that right even though, as Christie put it, “broad legalization of marijuana won’t, in my view, alleviate or even minimize the opioid crisis.”

It’s unclear what’s behind the apparent shift from hardline prohibitionist to wary federalist, but who knows… maybe Christie experienced an epiphany at a Melissa Etheridge concert he attended earlier this month.

Etheridge, who recently spoke with Marijuana Moment about her cannabis advocacy and use of the drug for medicinal purposes, reacted to a tweet showing Christie at one of her recent performances, where he reportedly knew every word of her songs and sang along.

Christie, for his part, replied that he “enjoyed every minute of a great performance and a truly wonderful group of fans.”

Hm…

GIF by #ActionAliens

Melissa Etheridge Talks Art, Culture and Marijuana Advocacy In The Legalization Era

Photo courtesy of Gage Skidmore.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

Marijuana Support Grows: Two Out Of Three Americans Back Legalization, Gallup Says

Published

on

Two-thirds of Americans now support legalizing marijuana, the highest percentage ever in Gallup’s ongoing decades-long series of national polls on the topic.

The new survey released on Monday shows that U.S. adults back ending cannabis prohibition by a supermajority margin of 66 percent to 32 percent. That’s more than a two-to-one ratio.

Please visit Forbes to read the rest of this piece.

(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)

Photo courtesy of Jurassic Blueberries.

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading

Politics

North Dakota Marijuana Legalization Measure Winning In Latest Poll

Published

on

North Dakota voters appear poised to legalize marijuana via a ballot measure next month, according to a new poll.

Measure 3, which would legalize cannabis for adults 21 and over in one of the country’s most conservative states—and with no possession limits—is ahead among likely voters by a margin of 51 percent to 36 percent in the survey released on Sunday.

North Dakota has brought marijuana policy reform supporters pleasant surprises before. Medical cannabis was approved there by an overwhelming majority of voters in 2016, for example, and will be available to patients sometime in 2019.

And despite little pro-legalization funding and relatively large spending in opposition to the ballot measure—a flip of the usual paradigm seen in most other states with cannabis initiatives—libertarian-leaning and younger voters on the prairie appear to be pushing Measure 3 towards a slim victory.

The results sharply contrast to those of another poll released earlier this month, which found the marijuana measure losing, 59 percent to 30 percent.

And although legalization support was significantly larger than opposition in the new survey, 13 percent of the 412 respondents say they are still undecided, leaving the issue very much in balance in the lead up to Election Day.

Nonetheless, legalization advocates are pleased with the new polling result.

“Despite a big-money funded misinformation campaign from the opposition, this poll reveals that most North Dakotans are ready to end the failed prohibition of marijuana in the state,” NORML Executive Director Erik Altieri said in a press release. “By voting ‘Yes’ on Measure 3, North Dakotans could save the state millions of taxpayer dollars currently being spent on arresting otherwise law-abiding adults for possession of a plant that is objectively less harmful than legal alcohol and tobacco, allow law enforcement to allocate their limited resources to focus on violent crime, and defend individual freedom.”

But activists know that the opposition has more money, and aren’t taking anything for granted over the next few weeks.

“The message of ending marijuana arrests is resounding in North Dakota, and these results demonstrate that voters are hearing our call for action. This is a dogfight, and LegalizeND will continue to set the record straight when it comes to adult-use marijuana,” Cole Haymond, a campaign advisory for Legalize ND, said.

Consistent with other states where medical marijuana has become legal, the measure performed best with voters under 50 in the new poll. Fifty-seven percent of respondents were 50 or older, suggesting that if younger voters turn out on Election Day, the measure may stand an even better chance of success.

“Passage of Measure 3 is greatly dependent upon the voters under the age of 50 voting in at least their historical percentages,” reads a polling memo by The Kitchens Group, which conducted the survey. “If the electorate is skewed toward the older, more conservative voters, passage could be problematic.”

But Measure 3 is being sold to voters on a personal responsibility platform, with emphasis on harsher penalties for sales to minors—and on marijuana’s proven ability to alleviate opiate-related overdoses and deaths.

When these aspects of the ballot measure were mentioned to poll respondents, support increased by the end of the eight-question survey.

Both before and after the push-polling, the percentage of voters who said they would “definitely” vote no stayed at a consistent 29 percent, suggesting that North Dakota has only a hardcore minority of prohibition-minded voters, with many more undecideds and pro-legalization voters.

The ballot measure is very far-reaching compared to those proposed in other states. It would allow possession, cultivation and sales of marijuana, with no set limits, though lawmakers would almost certainly enact regulations in the event of the measure’s passage. It would also expunge prior cannabis convictions.

The poll was conducted between October 11 and 14, and has a margin of error or +/- 4.9 percentage points.

Voters in seven states will consider marijuana ballot measures on Election Day this year.

An earlier version of this article incorrectly stated that Measure 3 legalized only small amounts of marijuana. The text of Measure 3 legalizes marijuana for adults 21 and over with no possession limits. This article has been updated.

North Dakota’s Marijuana Legalization Supporters Outraised By Opponents, Filings Show

If you value staying updated on cannabis news, please start a monthly Patreon pledge to support Marijuana Moment!
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox